WH Smith director goes to the till
23rd Apr 2012 15:43
Jeff Harris, a Non-Executive Director at WH Smith, purchased 10,000 shares in the stationery and book retailer on Friday, one day after the firm's interim results. Harris, currently the Chairman of FTSE 250 speciality plastic and fibre products supplier Filtrona who joined WH Smith's board in June
Read moreC&W Comms rallies as boss buys
27th Jun 2011 15:51
Shares in Cable & Wireless Communications were in demand Monday after it revealed the telecom company's chief executive Anthony Rice shelled out nearly £1m on shares. Rice bought 2.5m shares at 37.63p a pop. His latest purchase comes on the back of steady falls in the company's share price followin
Read moreDaly buys at BAT
1st Oct 2010 16:31
British American Tobacco's chief operating officer John Daly has invested nearly £511,000 in shares in the tobacco company. He has bought 21,200 shares at 2408.57p each and that takes his beneficial stake to 52,417 shares. Daly joined BAT as a result of its merger with Rothmans in 1999. He was a
Read moreSector movers: Imperial update lights up tobacco
22nd Sep 2010 14:08
The tobacco sector is higher after a well-received trading statement from Imperial Tobacco. The Lambert & Butler maker says it is still on track to meet forecasts for the year, though growth in tobacco revenues has slowed slightly over the last six months. Peer British American is slightly in the
Read moreBrainjuicer doubles profits
22nd Sep 2010 13:42
International online market researcher Brainjuicer moved close to a 52-week high Wednesday after well received interim figures that saw fully diluted earnings per share double from last year, Revenue for the first half of 2010 surged 49% to £7.2m from £4.8m last year, with the UK business returning
Read moreSmall caps: Silence Therapeutics, Eros, Interquest,...
14th Jul 2010 14:01
Silence Therapeutics has agreed a one-year extension of its ongoing research and development collaboration with AstraZeneca. The pair are working on five therapeutic molecules addressing respiratory and oncology indications. Film distributor Eros traded well in the second half of the financial year
Read moreBrainJuicer Group 1H Revenue Up 48%, Sees FY In Line With Views
14th Jul 2010 08:18
LONDON (Dow Jones)--BrainJuicer Group PLC (BJU.LN), an international online market research agency, said Wednesday it has made further encouraging progress during the first half of 2010 with overall revenue growth of 48%, driven primarily by the businesses in the U.K. and the U.S.. MAIN FACTS:
Read moreBrainJuicer squeezes more from US clients
9th Mar 2010 13:23
BrainJuicer sits at a two-year high after the online market researcher ramped up full-year profit by a fifth despite the recession and earned more money overseas. Pre-tax profit jumped to £1.66m from £1.37m in 2008. Strong growth in the US and Netherlands, and maiden full-year contributions from ne
Read moreBrainjuicer overcomes UK downturn
22nd Sep 2009 07:52
Market researcher BrainJuicer has lifted half-year profit and revenue despite the recession and says client spend appears to be opening up as the traditionally strong fourth quarter nears. The firm, whose clients include Unilever and Nike, reported pre-tax profit up 6% to £243,000 in the six month
Read moreSmall caps round-up: Brainjuicer, ReNeuron, Hamworthy...
8th Jul 2009 10:55
Market researcher BrainJuicer, whose clients include Unilever and Nike, posted revenue growth of about 22% for the first half and said it expects to make further progress in 2009. Stem cell therapy developer ReNeuron said clinical data on its lead CTX neural stem cell line in stroke and neurodegene
Read more